SightfileU.S. market data from official filings

ELECTROMED INC (ELMD)

Name: ELECTROMED INC (ELMD) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001488917 · EDGAR filings · Updated 2026-07-02

ELECTROMED INC (ELMD) has reported institutional ownership of 53.5%, with 101 institutional managers holding positions valued at $103.7M per the latest 13F reporting period.

Institutional ownership

53.5%

Institutional managers

101

Reported 13F value

$103.7M

Insider activity

16 trans.

−$1.60M net selling

Latest updates

2026-07-02 — Insider transaction reported (Form 4)
2026-06-09 — Insider transaction reported (Form 4)
2026-06-08 — Insider transaction reported (Form 4)
2026-06-08 — Notice of proposed sale filed (Form 144)
2026-06-04 — Notice of proposed sale filed (Form 144)
2026-05-29 — SD filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ELECTROMED INC has 101 institutional holders and institutional ownership of 53.5%.

Insider activity

Insiders reported 16 transactions (0 buys, 5 sells) across 9 reporting insiders, with a net reported value of −$1.60M.

Related companies

ARTIVA BIOTHERAPEUTICS INC (ARTV) · Kalaris Therapeutics Inc (KLRS) · PRELUDE THERAPEUTICS INC (PRLD) · SILENCE THERAPEUTICS PLC (SLN) · ZENTALIS PHARMACEUTICALS INC (ZNTL) · COHERUS ONCOLOGY INC (CHRS)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.